Elagolix to medically treat a uterine adenomyoma: A case report
Case report
OA: closed
CC0
⤵ 12 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This case report describes the successful medical management of uterine adenomyoma using elagolix, a GnRH antagonist.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (5)
- Long-Term Outcomes of Elagolix in Women With Endometriosis: Results From Two Extension Studies via openalex
- Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist via openalex
- W2033363713 via openalex
- W2065386825 via openalex
- W3002354512 via openalex
Cited by (12)
- Bleeding vs Thrombosis: Treatment Strategy for Women Having Large Uterine Fibroids and DVT 2024
- The suture fixation of the levonorgestrel-releasing intrauterine device with hysteroscope for the treatment of adenomyosis in patients at high risk of device expulsion 2024
- The Present and the Future of Medical Therapies for Adenomyosis: A Narrative Review 2023
- Suture fixation of the levonorgestrel-releasing intrauterine device with hysteroscope for the treatment of adenomyosis in patients at high risk of device expulsion 2023
- The Asian Society of Endometriosis and Adenomyosis guidelines for managing adenomyosis 2023
- Low-dose letrozole - an effective option for women with symptomatic adenomyosis awaiting IVF: a pilot randomized controlled trial 2023
- Changes in adenomyosis following elagolix vs leuprolide treatment in a patient with pelvic pain and infertility: A case report 2023
- Gynecological uses of GnRH antagonists: review article 2022
- Medical Treatment of Adenomyosis 2022
- Current and Prospective Treatment of Adenomyosis 2021
- Diagnostic steps in adenomyosis – an updated review 2021
- Elagolix in the treatment of heavy menstrual bleeding associated with uterine fibroids in premenopausal women 2021
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:26:49.206298+00:00
License: CC0
· commercial use OK